An expanded access program (EAP) provides patients and healthcare professionals with access to experimental pharmaceuticals that have been pre-approved for usage outside of clinical trials. Patients ...

This article presents a systematic review of US health care disparities in biologics access across immunology (ie, rheumatology, dermatology, and gastroenterology) and a call to action. Objectives: ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

The IMF Executive Board concluded the Comprehensive Review of the General Resources Account (GRA) Access Limits. The decision maintains the overall annual and cumulative GRA access limits at 200 and ...